Laserscope is a leading provider of medical laser systems for surgical and aesthetic applications. Founded in 1984, we are a pioneer developer of innovative technologies with over 5000 lasers installed worldwide in doctors’ offices, out-patient surgical centers and hospitals. Laserscope primarily serves the needs of two medical specialties: urology and aesthetic surgery. Our newest product offers a breakthrough treatment for a urological disorder called benign prostatic hyperplasia (BPH), an enlargement of the prostate gland experienced by most men after the age of fifty. For aesthetic applications, we offer a full line of products used to perform a wide variety of treatments including the removal of leg and facial veins, unwanted hair, pseudo-folliculitis and wrinkles. Laserscope is deeply dedicated to customer satisfaction.


Roy Fiebiger (President/CEO)

Peter Hadrovic (General Counsel)

Kester Nahen (VP Application Research)

Van Frazier (VP Quality Assurance & Regulatory Affairs)

Robert Mathews (VP Operations & Product Development)

View more details about all 13 people at Laserscope